Literature DB >> 3101020

Electroretinographic findings in the mucopolysaccharidoses.

R C Caruso, M I Kaiser-Kupfer, J Muenzer, I H Ludwig, M A Zasloff, P A Mercer.   

Abstract

The degree of retinal involvement of 20 patients (ages 3-21) with mucopolysaccharidosis (MPS) types I, II, and III was assessed using electroretinography (ERG) under standardized conditions. ERG evidence of retinal dysfunction ranged from none to severe in MPS I and II, and from moderate to severe in MPS III. The ERG abnormalities were common to all three types of MPS, and showed the pattern seen in rod-cone degenerations, where the rod-mediated responses are more severely affected than the cone-mediated responses. The ophthalmoscopic signs were less striking than the electrophysiologic findings, and were usually restricted to mild changes of the retinal pigment epithelium.

Entities:  

Mesh:

Year:  1986        PMID: 3101020     DOI: 10.1016/s0161-6420(86)33537-1

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  13 in total

1.  [Diffuse stromal corneal opacity and alterations of the hands].

Authors:  I M Lanzl; S-F Seidova; A Erben; K Thürmel; K Kotliar
Journal:  Ophthalmologe       Date:  2010-04       Impact factor: 1.059

2.  High-speed, ultrahigh resolution optical coherence tomography of the retina in Hunter syndrome.

Authors:  Michael K Yoon; Royce W Chen; Thomas R Hedges; Vivek J Srinivasan; Iwona Gorczynska; James G Fujimoto; Maciej Wojtkowski; Joel S Schuman; Jay S Duker
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2007 Sep-Oct

3.  Attempted enzyme replacement using human amnion membrane implantations in mucopolysaccharidoses.

Authors:  J Muenzer; E F Neufeld; G Constantopoulos; R C Caruso; M I Kaiser-Kupfer; A Pikus; J Danoff; R R Berry; H D McDonald; J N Thompson
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

4.  Does enzyme replacement therapy influence the ocular changes in type VI mucopolysaccharidosis?

Authors:  Susanne Pitz; Olufunmilola Ogun; Laila Arash; Elke Miebach; Michael Beck
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-01-22       Impact factor: 3.117

5.  Macular Changes in a Mucopolysaccharidosis Type I Patient with Earlier Systemic Therapies.

Authors:  Augusto Magalhães; Ana Maria Cunha; Rodrigo Vilares-Morgado; Elisa Leão-Teles; Esmeralda Rodrigues; Manuel Falcão; Ângela Carneiro; Jorge Breda; Fernando Falcão-Reis
Journal:  Case Rep Ophthalmol Med       Date:  2021-04-12

6.  Enzyme replacement therapy for Mucopolysaccharidosis Type I among patients followed within the MPS Brazil Network.

Authors:  Alícia Dorneles Dornelles; Louise Lapagesse de Camargo Pinto; Ana Carolina de Paula; Carlos Eduardo Steiner; Charles Marques Lourenço; Chong Ae Kim; Dafne Dain Gandelman Horovitz; Erlane Marques Ribeiro; Eugênia Ribeiro Valadares; Isabela Goulart; Isabel C Neves de Souza; João Ivanildo da Costa Neri; Luiz Carlos Santana-da-Silva; Luiz Roberto Silva; Márcia Ribeiro; Ruy Pires de Oliveira Sobrinho; Roberto Giugliani; Ida Vanessa Doederlein Schwartz
Journal:  Genet Mol Biol       Date:  2013-02-28       Impact factor: 1.771

7.  Bull's eye maculopathy and subfoveal deposition in two mucopolysaccharidosis type I patients on long-term enzyme replacement therapy.

Authors:  Heather G Mack; R C Andrew Symons; Gerard de Jong
Journal:  Am J Ophthalmol Case Rep       Date:  2017-10-04

8.  A case study of three patients with mucopolysaccharidoses in Hue Central Hospital.

Authors:  Tran Kiem Hao; Nguyen Thi Diem Chi; Nguyen Thi Hong Duc; Nguyen Thi Kim Hoa
Journal:  SAGE Open Med Case Rep       Date:  2020-06-29

9.  Negative ERGs in mucopolysaccharidoses (MPS) Hurler-Scheie (I-H/S) and Hurler (I-H)-syndromes.

Authors:  D Tzetzi; R Hamilton; P H Robinson; G N Dutton
Journal:  Doc Ophthalmol       Date:  2007-02-16       Impact factor: 1.854

10.  Electrophysiological and Histological Characterization of Rod-Cone Retinal Degeneration and Microglia Activation in a Mouse Model of Mucopolysaccharidosis Type IIIB.

Authors:  Dennis Y Tse; Parisa Lotfi; David L Simons; Marco Sardiello; Samuel M Wu
Journal:  Sci Rep       Date:  2015-11-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.